Why wouldn't everyone? If rare earth prices go high enough, stay high enough, for long enough then Koppa might make money. I'm not of punting the wrong end of the industry cost-curve because it usually ends in tears... but this time might be different. DyTb is available in other ICD's but also in xenotime. Lots of xenotime in mineral sand deposits, some hard rock deposits. If the prices of RE stay too high, what is the chance of substitution with new tech (magnets or motors)... just doesn;t make sense to me but I'm not privy to what hasn;t been released and maybe RE prices have a lot higher to run (except all the competitors will be making better money).
Only time will tell if the price falls back, is slowly walked back into a steady stream of punters buying the bargain 'dip' over the next 3-6 months, or it keeps running because I simply don't get it. No harm in having a contrarian test the new zeitgeist...
- Forums
- ASX - By Stock
- Ann: Updated Koppamurra resource announcement
AR3
australian rare earths limited
Add to My Watchlist
1.85%
!
5.5¢

Why wouldn't everyone? If rare earth prices go high enough, stay...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $11.65M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.2¢ | $24.26K | 451.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1766 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 18364 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1766 | 0.054 |
2 | 104634 | 0.053 |
2 | 23000 | 0.052 |
5 | 168607 | 0.051 |
8 | 288932 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 18364 | 2 |
0.056 | 119317 | 3 |
0.058 | 50000 | 1 |
0.060 | 39292 | 2 |
0.061 | 146716 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AR3 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online